SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010935
Filing Date
2019-11-13
Accepted
2019-11-13 16:18:01
Documents
72
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ymab-20190930x10q.htm 10-Q 1910713
2 EX-31.1 ymab-20190930ex311bcf723.htm EX-31.1 20163
3 EX-31.2 ymab-20190930ex312be109b.htm EX-31.2 20061
4 EX-32.1 ymab-20190930ex32120600a.htm EX-32.1 9839
5 EX-32.2 ymab-20190930ex322caffe0.htm EX-32.2 9797
  Complete submission text file 0001558370-19-010935.txt   5133001

Data Files

Seq Description Document Type Size
6 EX-101.INS ymab-20190930.xml EX-101.INS 649993
7 EX-101.SCH ymab-20190930.xsd EX-101.SCH 48888
8 EX-101.CAL ymab-20190930_cal.xml EX-101.CAL 38522
9 EX-101.DEF ymab-20190930_def.xml EX-101.DEF 161189
10 EX-101.LAB ymab-20190930_lab.xml EX-101.LAB 384894
11 EX-101.PRE ymab-20190930_pre.xml EX-101.PRE 327414
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38650 | Film No.: 191214205
SIC: 2834 Pharmaceutical Preparations